Zenas BioPharma to host obexelimab IgG4-RD investor event
Zenas BioPharma says it will host an investor event focused on obexelimab for IgG4-RD.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.